MedPath

Tuscaloosa Research & Education Advancement Corporation

Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

15

Active:0
Completed:9

Trial Phases

4 Phases

Phase 2:1
Phase 3:1
Phase 4:6
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials

Phase 4
6 (54.5%)
Not Applicable
3 (27.3%)
Phase 2
1 (9.1%)
Phase 3
1 (9.1%)

Minds Navigating the Diagnosis of Mild Cognitive Impairment

Not Applicable
Recruiting
Conditions
Mild Cognitive Impairment
Cognitive Dysfunction
First Posted Date
2023-01-19
Last Posted Date
2023-11-24
Lead Sponsor
Tuscaloosa Research & Education Advancement Corporation
Target Recruit Count
160
Registration Number
NCT05690243
Locations
🇺🇸

Tuscaloosa VA Medical Center, Tuscaloosa, Alabama, United States

🇺🇸

Salem VA Medical Center, Salem, Virginia, United States

Alabama Veterans Rural Health Initiative

Not Applicable
Completed
Conditions
Problems With Access to Health Care
Health Behavior
First Posted Date
2011-07-14
Last Posted Date
2018-04-23
Lead Sponsor
Tuscaloosa Research & Education Advancement Corporation
Target Recruit Count
203
Registration Number
NCT01394081
Locations
🇺🇸

Birmingham VAMC, Birmingham, Alabama, United States

🇺🇸

Tuscaloosa VAMC, Tuscaloosa, Alabama, United States

Impact of Supported Employment Versus Standard Vocational Rehabilitation in Veterans With Post-traumatic Stress Disorder

Not Applicable
Conditions
PTSD
First Posted Date
2008-08-05
Last Posted Date
2013-12-05
Lead Sponsor
Tuscaloosa Research & Education Advancement Corporation
Target Recruit Count
100
Registration Number
NCT00728325
Locations
🇺🇸

Birmingham VA Medical Center, Birmingham, Alabama, United States

🇺🇸

Tuscaloosa VA Medical Center, Tuscaloosa, Alabama, United States

🇺🇸

Bedford VA Medical Center, Bedford, Massachusetts, United States

Nepicastat for Posttraumatic Stress Disorder (PTSD) in OIF/OEF Veterans

Phase 2
Completed
Conditions
Posttraumatic Stress Disorder
Interventions
Drug: Placebo
First Posted Date
2008-04-16
Last Posted Date
2017-10-13
Lead Sponsor
Tuscaloosa Research & Education Advancement Corporation
Target Recruit Count
100
Registration Number
NCT00659230
Locations
🇺🇸

Tuscaloosa VAMC, Tuscaloosa, Alabama, United States

🇺🇸

VA San Diego Healthcare System, San Diego, California, United States

🇺🇸

James J.Peters VA Medical Center, The Bronx, New York, United States

Characterization of Recently Deployed Veterans

Completed
Conditions
Posttraumatic Stress Disorder
First Posted Date
2007-03-23
Last Posted Date
2007-03-23
Lead Sponsor
Tuscaloosa Research & Education Advancement Corporation
Target Recruit Count
500
Registration Number
NCT00451659
Locations
🇺🇸

TVAMC, Tuscaloosa, Alabama, United States

  • Prev
  • 1
  • 2
  • 3
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.